Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study

Journal of Affective Disorders

Volumn 65, Issue 2, 2001, Pages 173-177

  Furukawa, Toshiaki A ^a   Streiner, David L ^b   Young, L Trevor ^c  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Antidepressants; Benzodiazepines; Drug Therapy; Major depression

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENTAZEPAM; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONAZEPAM; DESIPRAMINE; DIAZEPAM; FLUNITRAZEPAM; FLUOXETINE; IMIPRAMINE; LORMETAZEPAM; MAPROTILINE; MEXAZOLAM; MIANSERIN; NORTRIPTYLINE; TRIAZOLAM;

ADULT; ARTICLE; CLINICAL TRIAL; DATA BASE; DEPRESSION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG RESPONSE; HAMILTON SCALE; HUMAN; MEDICAL INFORMATION; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SUBSTANCE-RELATED DISORDERS;

EID: 0035025922     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00254-8     Document Type: Article

References (17)

1. Berlin J.A., Laird N.M., Sacks H.S., Chalmers T.C. A comparison of statistical methods for combining event rates from clinical trials. Stat. Med. 8:1989;141-151.
2. Birkenhager T.K., Moleman P., Nolen W.A. Benzodiazepines for depression? A review of the literature. Int. Clin. Psychopharmacol. 10:1995;181-195.
3. Dominguez R.A., Jacobson A.F., Goldstein B.J., Steinbook R.M. Comparison of triazolam and placebo in the treatment of insomnia in depressed patients. Curr. Ther. Res. 36:1984;856-865.
4. Fawcett J., Edwards J.H., Kravitz H.M., Jeffriess H. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. J. Clin. Psychopharmacol. 7:1987;295-310.
5. Feet P.O., Larsen S., Robak O.H. A double blind study in out-patients with primary non-agitated depression treated with imipramine in combination with placebo, diazepam or dixyrazine. Acta Psychiatr. Scand. 72:1985;334-340.
6. Feighner J.P., Brauzer B., Gelenberg A.J., Gomez E., Kiev A., Kurland M.L., Weiss B.L. A placebo-controlled multicenter trial of Limbritol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology (Berl.). 61:1979;217-225.
7. Furukawa, T., Streiner, D.L., Young, L.T., 2000. Antidepressant plus benzodiazepine for major depression. In: The Cochrane Library, issue 3. Update Software, Oxford.
8. Neutel C.I. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann. Epidemiol. 5:1995;239-244.
9. Nolen W.A., Haffmans P.M.J., Bouvy P.F., Duivenvoorden H.J. Hypnotics as concurrent medication in depression: a placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant. J. Affect. Disord. 28:1993;179-188.
10. Ordonez A.C.C., Arosamene X., Perez F.J.O., Herrero C.H., Garcia A., Moral L., Baeza F., Benitez J.F., Velasco J., Garrido J. Clomipramine/bentazepam combination in the treatment of major depressive disorders. Hum. Psychopharmacol. 7:1992;115-122.
11. Sackett D.L., Richardson W.S., Rosenberg W., Haynes R.B. Evidence-Based Medicine: How to Practice and Teach EBM. 1997;Churchill Livingstone, New York.
12. Scharf M.B., Hirschowitz J., Zemlan F.P., Lichstein M., Woods M. Comparative effects of Limbitrol and amitriptyline on sleep efficiency and architecture. J. Clin. Psychiatry. 47:1986;587-591.
13. Schweizer E., Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr. Scand. Suppl. 393:1998;95-101.
14. Smith W.T., Londborg P.D., Glaudin V., Painter J.R. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am. J. Psychiatry. 155:1998;1339-1345.
15. Thornley B., Adams C.E., Awad G. Chlorpromazine versus placebo for those with schizophrenia. Cochrane Library. 1998;Update Software, Oxford.
16. Trindade E., Menon D. Selective Serotonin Reuptake Inhibitors (SSRIS) for Major Depression. Part I: Evaluation of the Clinical Literature (report 3E). 1997;Canadian Coordinating Office for Health Technology Assessment, Ottawa.
17. Yamaoka K. Augmentation therapy of antidepressant and benzodiazepine in treatment of depression. Seishinka Chiryo-Gaku (in Japanese). 9:1994;1349-1355.